| Financial Year |
March 31 2023 |
| Monetary Funds |
6,539,396,757.00 |
| Held-for-trading Financial Assets |
795,209,132.00 |
| Notes Receivable |
112,527,852.00 |
| Accounts Receivable |
2,112,295,498.00 |
| Advances to Suppliers |
143,757,761.00 |
| Other Receivables |
285,888,008.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
547,861,418.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
114,801,207.00 |
| Total Current Assets |
11,465,902,284.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,926,809.00 |
| Long-term Equity Investment |
2,711,489,284.00 |
| Investment Properties |
-- |
| Fixed Assetes |
2,344,886,816.00 |
| Under-construction Projects |
155,722,335.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,703,621,304.00 |
| R&D expenses |
428,782,728.00 |
| Goodwill |
1,600,764,166.00 |
| Long-Term Deferred and Prepaid Expenses |
27,927,634.00 |
| Deferred Income Tax Assets |
59,672,218.00 |
| Other Non-Current Assets |
70,981,306.00 |
| Sub-Total of Non-Current Assets |
11,425,185,150.00 |
| Total Assets |
22,891,087,434.00 |
| Short-Term Loans |
3,355,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
765,985,370.00 |
| Accounts Received In Advance |
22,390,371.00 |
| Employee Compensation Payable |
614,894,171.00 |
| Taxes Payable |
233,560,119.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
931,148,092.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
300,509,380.00 |
| Other Current Liabilities |
213,464,516.00 |
| Sub-Total of Current Liabilities |
8,747,904,041.00 |
| Long-term Loans |
1,411,750,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
50,580,245.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,251,199.00 |
| Other Non-Current Liabilities |
387,227,930.00 |
| Sub-Total of Non-Current Liabilities |
2,056,653,471.00 |
| Total Liabilities |
10,804,557,512.00 |
| Paid-In Capital(Or Share Stock) |
3,433,405,036.00 |
| Capital Surplus |
5,839,882,319.00 |
| Surplus Reserve |
1,324,594,716.00 |
| LESS:Treasury Stock |
1,193,126,026.00 |
| Undistributed Profits |
1,647,463,685.00 |
| Minority Stockholder's Interest |
1,032,433,200.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,054,096,722.00 |
| Owner's Equity（Stockholder's Equity） |
12,086,529,922.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,891,087,434.00 |
